Treatment with etanercept in 1019 Italian children with juvenile idiopathic arthriti: preliminary results

Donato Rigante, S Davì, S Verazza, A Consolaro, A Insalaco, V Gerloni, R Cimaz, F Zulian, L Lepore, F Corona, G Conti, P Barone, M Cattalini, E Cortis, L Breda, AN Olivieri, A Civino, F La Torre, G D'Angelo, R GallizziMC Maggio, R Consolini, A De Fanti, MG Alpigiani, A Martini, A. Ravelli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

All centers of the Italian Pediatric Rheumatology Study Group were asked in 2013 to make a census of patients given etanercept (ETN) after January 2000. Patients were classified in three groups: 1) patients still taking ETN; 2) patients discontinued from ETN for any reasons; 3) patients lost to follow-up while receiving ETN. All three groups received a retrospective assessment; patients in group 1 also underwent a cross-sectional assessment. The preliminary results of this investigation referred to 1019 patients have been listed in this report.
Lingua originaleEnglish
pagine (da-a)1239-1240
Numero di pagine2
RivistaANNALS OF THE RHEUMATIC DISEASES
Volume2015
Stato di pubblicazionePubblicato - 2015

Keywords

  • Juvenile idiopathic arthritis

Fingerprint Entra nei temi di ricerca di 'Treatment with etanercept in 1019 Italian children with juvenile idiopathic arthriti: preliminary results'. Insieme formano una fingerprint unica.

Cita questo